Bessemer Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.11M | Buy |
5,450
+1,153
| +27% | +$428K | ﹤0.01% | 840 |
|
|
2026
Q1 | $1.26M | Sell |
4,297
-138,897
| -97% | -$45.6M | ﹤0.01% | 906 |
|
|
2025
Q4 | $50.2M | Sell |
143,194
-4,178
| -3% | -$1.41M | 0.08% | 193 |
|
|
2025
Q3 | $47.6M | Buy |
147,372
+8,152
| +6% | +$2.54M | 0.07% | 189 |
|
|
2025
Q2 | $54.2M | Buy |
139,220
+493
| +0.4% | +$198K | 0.09% | 186 |
|
|
2025
Q1 | $60.3M | Sell |
138,727
-8,023
| -5% | -$3.22M | 0.11% | 172 |
|
|
2024
Q4 | $54.1M | Sell |
146,750
-243,785
| -62% | -$102M | 0.09% | 180 |
|
|
2024
Q3 | $203M | Buy |
390,535
+5,654
| +1% | +$3.02M | 0.33% | 81 |
|
|
2024
Q2 | $209M | Sell |
384,881
-5,765
| -1% | -$3.05M | 0.37% | 65 |
|
|
2024
Q1 | $203M | Sell |
390,646
-25,019
| -6% | -$12.4M | 0.37% | 75 |
|
|
2023
Q4 | $196M | Sell |
415,665
-4,683
| -1% | -$2.17M | 0.38% | 64 |
|
|
2023
Q3 | $183M | Buy |
420,348
+113,052
| +37% | +$51.3M | 0.4% | 61 |
|
|
2023
Q2 | $137M | Buy |
307,296
+35
| +0% | +$16.1K | 0.29% | 93 |
|
|
2023
Q1 | $141M | Sell |
307,261
-49,803
| -14% | -$23.7M | 0.34% | 89 |
|
|
2022
Q4 | $183M | Sell |
357,064
-35,428
| -9% | -$18M | 0.45% | 59 |
|
|
2022
Q3 | $178M | Buy |
392,492
+8,071
| +2% | +$3.86M | 0.47% | 51 |
|
|
2022
Q2 | $186M | Buy |
384,421
+3,960
| +1% | +$1.96M | 0.46% | 52 |
|
|
2022
Q1 | $187M | Buy |
380,461
+4,774
| +1% | +$2.18M | 0.39% | 77 |
|
|
2021
Q4 | $174M | Buy |
375,687
+4,873
| +1% | +$2.05M | 0.35% | 86 |
|
|
2021
Q3 | $138M | Buy |
370,814
+2,795
| +0.8% | +$1.06M | 0.29% | 113 |
|
|
2021
Q2 | $141M | Buy |
368,019
+13,978
| +4% | +$5.34M | 0.31% | 100 |
|
|
2021
Q1 | $127M | Buy |
354,041
+113,091
| +47% | +$36.4M | 0.3% | 103 |
|
|
2020
Q4 | $77.4M | Buy |
240,950
+312
| +0.1% | +$95.7K | 0.2% | 137 |
|
|
2020
Q3 | $64.6M | Buy |
240,638
+25,755
| +12% | +$6.93M | 0.19% | 129 |
|
|
2020
Q2 | $56.5M | Sell |
214,883
-1,834
| -0.8% | -$489K | 0.18% | 130 |
|
|
2020
Q1 | $49.2M | Buy |
216,717
+200,104
| +1,205% | +$54.5M | 0.2% | 127 |
|
|
2019
Q4 | $5.02M | Buy |
16,613
+629
| +4% | +$173K | 0.02% | 331 |
|
|
2019
Q3 | $3.84M | Buy |
15,984
+2,158
| +16% | +$591K | 0.01% | 357 |
|
|
2019
Q2 | $3.9M | Buy |
13,826
+781
| +6% | +$213K | 0.01% | 366 |
|
|
2019
Q1 | $3.74M | Sell |
13,045
-3,750
| -22% | -$1.08M | 0.01% | 325 |
|
|
2018
Q4 | $4.41M | Sell |
16,795
-444,675
| -96% | -$122M | 0.02% | 234 |
|
|
2018
Q3 | $126M | Sell |
461,470
-2,010
| -0.4% | -$522K | 0.47% | 80 |
|
|
2018
Q2 | $110M | Buy |
463,480
+424,775
| +1,097% | +$98.4M | 0.43% | 84 |
|
|
2018
Q1 | $8.5M | Buy |
38,705
+2,699
| +7% | +$634K | 0.03% | 219 |
|
|
2017
Q4 | $8.1M | Buy |
36,006
+937
| +3% | +$200K | 0.03% | 227 |
|
|
2017
Q3 | $6.66M | Buy |
35,069
+1,023
| +3% | +$195K | 0.03% | 250 |
|
|
2017
Q2 | $6.41M | Sell |
34,046
-3,302
| -9% | -$593K | 0.03% | 258 |
|
|
2017
Q1 | $6.18M | Buy |
37,348
+12,424
| +50% | +$1.98M | 0.03% | 291 |
|
|
2016
Q4 | $3.58M | Buy |
24,924
+986
| +4% | +$132K | 0.02% | 371 |
|
|
2016
Q3 | $3M | Sell |
23,938
-29,627
| -55% | -$3.83M | 0.02% | 357 |
|
|
2016
Q2 | $7.04M | Buy |
53,565
+891
| +2% | +$122K | 0.04% | 248 |
|
|
2016
Q1 | $7.32M | Buy |
52,674
+9,431
| +22% | +$1.26M | 0.04% | 226 |
|
|
2015
Q4 | $6.03M | Buy |
43,243
+118
| +0.3% | +$16.3K | 0.03% | 222 |
|
|
2015
Q3 | $6.04M | Buy |
43,125
+3,060
| +8% | +$460K | 0.03% | 216 |
|
|
2015
Q2 | $6.58M | Buy |
40,065
+11,153
| +39% | +$1.78M | 0.03% | 219 |
|
|
2015
Q1 | $4.46M | Sell |
28,912
-15,943
| -36% | -$2.27M | 0.02% | 274 |
|
|
2014
Q4 | $5.64M | Sell |
44,855
-1,810
| -4% | -$224K | 0.03% | 242 |
|
|
2014
Q3 | $5.58M | Buy |
46,665
+14
| +0% | +$1.61K | 0.03% | 239 |
|
|
2014
Q2 | $5.02M | Buy |
46,651
+340
| +0.7% | +$35K | 0.03% | 237 |
|
|
2014
Q1 | $4.61M | Buy |
46,311
+34,400
| +289% | +$3.11M | 0.03% | 226 |
|
|
2013
Q4 | $1.1M | Buy |
11,911
+1,000
| +9% | +$88.9K | 0.01% | 428 |
|
|
2013
Q3 | $912K | Buy |
10,911
+10,686
| +4,749% | +$916K | 0.01% | 428 |
|
|
2013
Q2 | $18K | Buy |
+225
| New | +$16.8K | ﹤0.01% | 938 |
|
Other funds holding ELV
Bessemer Group's ELV Position: Q2 2026 in Review
Bessemer Group increased its Elevance Health (ELV) stake by 27% in Q2 2026, buying an estimated $428K and bringing the position to 5,450 shares worth $2.11M. The position accounts for ﹤0.01% of the portfolio, ranked #840.
Bessemer Group first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $209M in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Bessemer Group held 5,450 shares of Elevance Health worth $2.11M as of Q2 2026.
- Bessemer Group bought 1,153 Elevance Health shares in Q2 2026, an estimated $428K.
- Elevance Health made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #840 holding.
- Bessemer Group first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
- Bessemer Group's Elevance Health position peaked at $209M in Q2 2024.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.